Muhammad Amirul Mukminin

Muhammad Amirul Mukminin

Auto-generated profile, based on publicly available information

Muhammad Amirul Mukminin

School of Nursing College of Nursing Taipei Medical University Taipei Taiwan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2024 in Narra J
Verified
Journal Article
Open access
PDF file
DRDiah Ratnawati
Diah Ratnawati
MHMega H. Huda
Mega H. Huda
MMMuhammad A. Mukminin
Muhammad A. Mukminin
WWWidyatuti Widyatuti
Widyatuti Widyatuti
ASAgus Setiawan
Agus Setiawan
The prevalence of human immunodeficiency virus (HIV) among adolescents is on the rise due to a lack of comprehensive knowledge, leading to suboptimal attitudes and behaviors, which emphasizes the critical need for targeted interventions. The aim of this review study was to evaluate the effectiveness of educational interventions for HIV prevention among adolescents by assessing their impact on knowledge, attitude, and behavior. A systematic review of seven databases: PubMed, Science Direct, Cochrane, JSTOR, Embase, Scopus, and EBSCO were identified, and 14 eligible randomized controlled trials published until June 2023 were included. Two independent authors assessed quality appraisal using the Risk of Bias 2.0. Outcomes were measured using the standard mean difference (SMD) with random effects model and a 95% confidence interval. Subgroup analyses and meta-regression were performed to explore heterogeneity. The results showed significant improvements in participants' knowledge (SMD: 1.13, 95%CI: 0.78–1.49), behavior intentions (SMD: 1.22, 95%CI: 0.37–2.07), and attitude (SMD: 0.48, 95%CI: 0.02–0.95) after receiving HIV prevention education programs. Interventions grounded in theoretical principles and incorporating technology, group settings, and audio-visual aids were found to be effective in enhancing knowledge of HIV prevention and promoting behavioral intentions. Peer-led education positively impacted both knowledge and attitude. Moreover, excluding parents from these programs was identified as a crucial factor in improving adolescents' knowledge of HIV prevention. In conclusion, educational programs focused on HIV effectively enhance adolescents' knowledge, attitudes, and behavioral intentions among adolescents. Professionals planning interventions should consider these impactful components in designing comprehensive strategies.

27 May 2025 in Tropical Medicine & International Health
Verified
Journal Article
Open access
LLLutfian Lutfian
Lutfian Lutfian
Izdihar Javier WardikaIzdihar Javier Wardika
Izdihar Javier Wardika
MMMuhammad Amirul Mukminin
Muhammad Amirul Mukminin
AZAsroful Hulam Zamroni
Asroful Hulam Zamroni
ARAyunda Puteri Rizanti
Ayunda Puteri Rizanti
Sidik MaulanaSidik Maulana
Sidik Maulana
Introduction: Chronic communicable diseases, such as tuberculosis, HIV, hepatitis B, and hepatitis C, remain major global health challenges. Effective treatment adherence is crucial for improving patient outcomes and health education plays a key role in enhancing adherence. However, evidence for the most effective educational interventions remains limited.Objective: This study aimed to evaluate the effectiveness of health education interventions in improving treatment adherence among patients with chronic communicable diseases.Methods: A systematic review and meta‐analysis were conducted following the preferred item for systematic review and meta‐analysis (PRISMA) guidelines. Comprehensive searches were performed in PubMed, CINAHL, Scopus, and the Web of Science for studies published between 2015 and 2024. Eligible studies included randomised controlled trials. Quality assessment was conducted using the Joanna Briggs Institute critical appraisal tools. Statistical analysis was performed using the Mantel‐Haenszel method to estimate odds ratios (OR) and standardised mean differences (SMD) with 95% confidence intervals (CI) using a random effects model. Meta‐regression was conducted to explore potential sources of heterogeneity.Results: Seventeen studies involving 4,157 participants were included. Health education interventions significantly improved treatment adherence compared to usual care (OR 2.42; 95% CI: 1.58–3.72; p <0.0001). Subgroup analyses showed the highest effectiveness in remote‐based interventions (OR 5.65; 95% CI: 2.37–13.47), among patients with tuberculosis (OR 6.52; 95% CI: 3.59–11.84), and in upper‐middle‐income countries (OR 4.54; 95% CI: 1.54–13.39). Meta‐regression indicated that younger participant age and intervention type were significant moderators, with media‐based and remote‐based showing greater effectiveness.Conclusion: Health education interventions significantly improve treatment adherence among patients with chronic communicable diseases, particularly those with tuberculosis and hepatitis C. Remote‐based models, such as mHealth platforms and digital reminders, demonstrate the highest effectiveness, especially in low‐ and middle‐income countries where stigma and limited healthcare access remain key barriers.

2 December 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MHMega Hasanul Huda
Mega Hasanul Huda
MRMuhamad Fauzi Rahman
Muhamad Fauzi Rahman
YZYusuf Zalaya
Yusuf Zalaya
MMMuhammad Amirul Mukminin
Muhammad Amirul Mukminin
TPTelly Purnamasari
Telly Purnamasari
RSRiswal Nafi Siregar
Riswal Nafi Siregar
Various technology-based interventions have been designed to improve medication adherence and treatment success. However, research on the most effective mode to address this issue is still limited. Our study evaluated the effectiveness of technology-based interventions in improving treatment adherence, completion, and treatment success among tuberculosis (TBC) patients. We conducted a meta-analysis of randomized controlled trials by searching articles from six databases including PubMed, Science Direct, Cochrane, Jstor, Embase, and Scopus from 2018 to April 2023. Two independent reviewers assessed the study quality using the Cochrane Risk of Bias 2.0 tool. We analysed the data using a random-effects model. We also conducted publication bias and sensitivity analysis. In total, 13 studies were identified and 4,794 participants were included in the meta-analysis. The results indicated that technology-based interventions were effective in improving treatment adherence, completion, and success (Odds Ratio (OR): 2.57, 95% Confident Interval (CI): 1.01–6.50, I2 = 86.6%; OR: 1.77, 95% CI: 0.95–3.28, I2: 82.3%; OR: 1.61, 95% CI: 0.85–3.06, I2: 84%, respectively). We examined the possibility of publication bias in the published studies included in this systematic review. However, no evidence of publication bias was found. From the sensitivity analysis by removing one study randomly, we found that our results are robust. Based on the results, we can conclude that technology-based interventions like MERM, text-based messages, video conferencing, and VOT are effective in increasing treatment adherence and completion in tuberculosis management. Therefore, technology shows immense potential in enhancing patient outcomes.

1 July 2025 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
LLLutfian Lutfian
Lutfian Lutfian
Izdihar Javier WardikaIzdihar Javier Wardika
Izdihar Javier Wardika
MMMuhammad Amirul Mukminin
Muhammad Amirul Mukminin
IHIbnu Syarifudin Hidayat
Ibnu Syarifudin Hidayat
RWRiki Wartakusumah
Riki Wartakusumah
JHJonathan Hasian Haposan
Jonathan Hasian Haposan
Background: Type 2 Diabetes Mellitus (T2DM) presents a significant public health challenge, particularly in developing countries, where healthcare resources are limited. Community-Based Interventions (CBIs) have been explored as a strategy to improve glycemic control, yet evidence regarding their efficacy in reducing HbA1c levels in these settings remains limited. Aim: This study aimed to evaluate the efficacy of community-based interventions in improving HbA1c levels among patients with T2DM in developing countries. Methods: A systematic review and meta-analysis were performed following PRISMA guidelines. A comprehensive literature search was conducted in PubMed, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, Ovid-Medline, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases for full-text randomized controlled trials (RCTs) published between 2015 and 2024. Studies conducted in developing countries focusing on community-based interventions targeting HbA1c outcomes were included. Quality appraisal was conducted using the Joanna Briggs Institute (JBI) critical appraisal tools. Statistical analysis employed a random-effects model to calculate the pooled mean difference (MD) with 95% confidence intervals (CI). Heterogeneity was assessed using the I 2 statistic. Potential publication bias was assessed using Egger’s test, the Trim-and-Fill method, and a funnel plot. Results: Twenty RCTs involving 4914 participants across developing countries were included. CBIs significantly reduced HbA1c levels compared to usual care, with a pooled MD of −0.54 (95% CI = −0.71, −0.36; P < .00001; I 2 = 92%). Subgroup analysis showed that education-focused interventions (MD = −0.67; 95% CI = −1.02, −0.31) and physical activity-focused interventions (MD = −0.67; 95% CI = −1.14, −0.20) were the most effective. Analysis by income level revealed no significant differences in efficacy between lower-middle-income and upper-middle-income countries ( P = .29). The greatest HbA1c reduction was observed during the 0- to 3-month measurement period (MD = −0.56; 95% CI = −0.90, −0.23). Conclusion: CBIs are an effective strategy for reducing HbA1c levels among patients with T2DM in developing countries, with significant benefits across diverse economic contexts and intervention models. These findings highlight the adaptability and scalability of CBIs, underscoring their potential to enhance diabetes management in resource-limited settings.

31 August 2026 in Psycho-Oncology
Verified
Journal Article
Open access
PDF file
CLChen‐I Lee
Chen‐I Lee
MMMuhammad Amirul Mukminin
Muhammad Amirul Mukminin
YJYa‐Wen Jan
Ya‐Wen Jan
TWTzu‐Hao Wang
Tzu‐Hao Wang
THTsai-Wei Huang
Tsai-Wei Huang
HCHsiao‐Yean Chiu
Hsiao‐Yean Chiu
Background: Insomnia affects 30%–60% of cancer survivors, with around 20% meeting criteria for insomnia disorder. Cognitive behavioral therapy for insomnia (CBTi) is the first‐line treatment, but access is limited by cost and therapist availability, prompting exploration of alternative delivery modes, including digital interventions. Purpose: To systematically review and conduct a network meta‐analysis (NMA) of the efficacy of different CBTi delivery methods for managing insomnia in cancer survivors. Methods: The PubMed, Embase, CINAHL and Cochrane Library were searched for relevant articles published before September 25, 2025. Only randomized controlled trials of adult cancer patients evaluating the effects of any CBTi delivery mode on subjective sleep outcomes were included. Primary outcome was insomnia severity index (ISI) score; secondary outcomes included sleep onset latency (SOL), wake after sleep onset (WASO), total sleep time (TST), and sleep efficiency (SE). A frequentist random‐effects NMA was conducted. Results: Twenty‐two trials involving 2040 participants were included. Compared with treatment as usual (TAU), digital CBTi (dCBTi) demonstrated the largest reduction in ISI scores (MD = −9.70, 95% CI = −10.80 to −8.61), followed by telephone CBTi (MD = −8.74). dCBTi also significantly improved SOL (−30.95 min), WASO (−25.62 min), TST (+31.67 min), and SE (+14.63%). Group CBTi significantly improved SOL (−11.60 min) and WASO (−22.03 min). Meta‐regression analyses identified breast cancer diagnosis as a significant moderator of dCBTi effects on SOL (coefficient = 25.20, p = 0.015) and SE (coefficient = −16.17, p = 0.007). The certainty of evidence ranged from low to very low, primarily because of imprecision and network incoherence. Conclusions: dCBTi demonstrated the greatest potential for improving insomnia outcomes among the evaluated CBTi delivery modalities. However, given the low certainty of evidence and the presence of network inconsistency for selected outcomes, these findings should be interpreted cautiously. High‐quality head‐to‐head trials are needed to confirm the comparative effectiveness of different CBTi delivery modalities in oncology populations. Trial Registration: The study protocol was prospectively registered on PROSPERO (registration no. CRD42023429081)